MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · Alternative therapies in health and medicine · 2025

Comparative Efficacy of Traditional Unani Medicine Formulations Versus Apremilast for Chronic Plaque Psoriasis: A Randomized Controlled Trial.

Bashir Sabreena, Bhat Muzafar Din Ahmad, Jamal Mohd Arshad, Ayesha Ruksar

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Psoriasis remains an incurable and recurrent condition despite modern treatment. Traditional Unani Medicine recommends numerous formulations for psoriasis, but with little supporting scientific evidence.

PRIMARY STUDY

OBJECTIVES

The study aimed to evaluate the efficacy and safety of Majoon Mundi and Roghan Gul compared to apremilast and coconut oil in managing chronic plaque psoriasis (CPP).

METHODS/

DESIGN

The study was a randomized, open-label, standard-controlled clinical trial, with 33 participants. 20 patients completed the 6-week treatment course in the test group, while 10 patients completed the 6-week treatment course in the control group.

SETTING

The study was conducted at the National Institute of Unani Medicine (NIUM), Bangalore, India, from June 2021 to December 2021.

PARTICIPANTS

Participants aged 18-60 years, of either gender, diagnosed with CPP, and based on psoriasis area and severity index (PASI) score.

INTERVENTIONS: The participants in the test group received 10 g of Majoon Mundi orally twice daily after meals and Roghan Gul for topical use twice daily, while the participants in the active control group received apremilast orally in a titrated dose and coconut oil as a topical application twice daily.

OUTCOME MEASURES: The primary outcome of the study was a reduction in PASI score, and the secondary outcome was a reduction in dermatology life quality index (DLQI) score. Photographic assessments were conducted at the 14th, 28th, and 42nd day of the follow-up period.

RESULTS

Intragroup analyses revealed that the test and control groups experienced a statistically significant reduction in PASI and DLQI scores (P < .001). Intergroup analysis showed no statistically significant difference in the reduction of PASI and DLQI scores between groups (P = .772 and .775, respectively).

CONCLUSION

This study found that together, Majoon Mundi and Roghan Gul are as effective as apremilast and coconut oil in decreasing PASI and DLQI scores for managing CPP.

KEYWORDS: apremilast, comparative study, herbal medicine, psoriasis, unani medicine.

Для цитирования: Bashir Sabreena, Bhat Muzafar Din Ahmad, Jamal Mohd Arshad, Ayesha Ruksar. Comparative Efficacy of Traditional Unani Medicine Formulations Versus Apremilast for Chronic Plaque Psoriasis: A Randomized Controlled Trial.. Alternative therapies in health and medicine. 2025.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.